Skip to main content
. 2022 Oct 14;5(10):e2236357. doi: 10.1001/jamanetworkopen.2022.36357

Table 1. Baseline Characteristics According to Prediagnosis BMI Category.

Variable Patients, No. (%) P value
Total Normal (<25) Overweight (25-30) Obese (≥30)
No. of patients 656 251 (38.3) 238 (36.3) 167 (25.4) NA
Age at initial diagnosis, y
<45 135 (20.6) 80 (31.9) 29 (12.2) 26 (15.6) <.001
45-65 414 (63.1) 147 (58.6) 158 (66.4) 109 (65.3)
≥65 107 (16.3) 24 (9.6) 51 (21.4) 32 (19.2)
Sex
Men 376 (57.3) 80 (31.9) 176 (73.9) 120 (71.9) <.001
Women 280 (42.7) 171 (68.1) 62 (26.1) 47 (28.1)
Race
Black or Hispanic 105 (16.0) 34 (13.6) 40 (16.8) 31 (18.6) .03
Non-Hispanic White 501 (76.4) 188 (74.9) 183 (76.9) 130 (77.8)
Othera 50 (7.6) 29 (11.6) 15 (6.3) 6 (3.6)
Smokingb
Ever 256 (39.3) 85 (34.0) 89 (37.6) 82 (50.0) .004
Never 395 (60.7) 165 (66.0) 148 (62.4) 82 (50.0)
Diabetesc
Yes 92 (14.2) 18 (7.2) 31 (13.2) 43 (26.1) <.001
No 556 (85.8) 231 (92.8) 203 (86.8) 122 (73.9)
Stage at diagnosisd
I 18 (2.8) 7 (2.8) 8 (3.4) 3 (1.8) .15
II 53 (8.1) 17 (6.8) 17 (7.2) 19 (11.5)
III 196 (30.1) 86 (34.5) 59 (25.0) 51 (30.7)
IV 384 (59.0) 139 (55.8) 152 (64.4) 93 (56.0)
Total KRAS variations 549 206 (37.5) 199 (36.3) 144 (26.2)
WT 272 (49.5) 104 (50.5) 93 (46.7) 75 (52.1) .75
Canonical 270 (49.2) 100 (48.5) 102 (51.3) 68 (47.2)
Noncanonical 7 (1.3) 2 (1.0) 4 (2.0) 1 (0.7)
Total PIK3CA variations 474 187 (39.5) 170 (35.9) 117 (24.7)
WT 364 (76.8) 143 (76.5) 124 (72.9) 97 (82.9) .14
Mutant 110 (23.2) 44 (23.5) 46 (27.1) 20 (17.1)
Tumor locatione 622 237 (38.1) 224 (36.0) 161 (25.9)
Right 215 (34.6) 75 (31.7) 83 (37.1) 57 (35.4) .48
Left 277 (44.5) 110 (46.4) 91 (40.6) 76 (47.2)
Rectum 130 (20.9) 52 (21.9) 50 (22.3) 28 (17.4)

Abbreviations: BMI, body mass index; WT, wild-type variation.

a

Other race includes Asian or Pacific Islander, American Indian or Alaska Native, and other or not specified.

b

Results on smoking include 5 missing data, including 1 patient with normal, 1 with overweight, and 3 with obese BMI.

c

Results on diabetes include 8 missing data, including 2 patients with normal, 4 with overweight, and 2 with obese BMI.

d

Results on stage at diagnosis include 5 missing data, including 2 patients with normal, 2 with overweight, and 1 with obese BMI.

e

Data missing on 34 tumors, including for 14 patients with normal, 14 with overweight, and 6 with obese BMI.